2013 Apr 15 Annual Report 2012 - Phosphagenics

More documents

Recommendations

Info

Directors’ Report continued NON-AUDIT SERVICES The Directors are satisfi ed that the provision of non-audit services, during the year, by the auditor (or by another person or fi rm on the auditor’s behalf) is compatible with the general standard of independence for auditors imposed by the Corporations Act 2001. Details of amounts paid or payable to the auditor for non-audit services provided during the year by the auditor are outlined in note 6 to the fi nancial statements. AUDITOR’S INDEPENDENCE DECLARATION The auditor’s independence declaration is included on page 20 of the fi nancial report. CHANGES IN STATE OF AFFAIRS During the fi nancial year there was no signifi cant change in the state of affairs of the consolidated entity other than that referred to in the fi nancial statements or notes thereto. SUBSEQUENT EVENTS There has not been any matter or circumstance, other than that referred to in the fi nancial statements or notes thereto, that has arisen since the end of the fi nancial year, that has signifi cantly affected, or may signifi cantly affect, the operations of the consolidated entity, the results of those operations, or the state of affairs of the consolidated entity in future fi nancial years. 52 Signed in accordance with a resolution of the Directors made pursuant to s.298(2) of the Corporations Act 2001. Jonathan Lancelot Addison Chairman 19 February 2013 Melbourne PHOSPHAGENICS ANNUAL REPORT 2012
Auditors Independence Declaration 53 DIRECTOR’S REPORT
Page 1 and 2:
20 12 Annual Report PHOSPHAGENICS P
Page 3 and 4: highlights March... April... May...
Page 5 and 6: 03 Jonathan Addison Chairman & Inde
Page 7 and 8: COLLABORATIONS Strategic Collaborat
Page 9 and 10: The Phosphagenics Evolution THE STO
Page 11 and 12: “ We also reached agreement with
Page 13 and 14: Overview of our opioid development
Page 15 and 16: 13 is branded as Butrans or Norspan
Page 17 and 18: Personal Care ASHLAND INC (FORMERLY
Page 19 and 20: BEAUTY IS MORE THAN SKIN DEEP 17 EL
Page 21 and 22: cellulite contour crème BioElixia
Page 23 and 24: Intellectual Property Title Countri
Page 25 and 26: 2009 2008 2007 2006 6.8 7.8 22.2 23
Page 27 and 28: DR ESRA OGRU (AGED 37 YEARS) BSC (H
Page 29 and 30: Senior Management DR PAUL GAVIN Chi
Page 31 and 32: Phosphagenics Limited ABN 32 056 48
Page 33 and 34: Directors’ Report Your directors
Page 35 and 36: Directors’ Report continued Looki
Page 37 and 38: Directors’ Report continued Commi
Page 39 and 40: Directors’ Report continued REMUN
Page 41 and 42: Directors’ Report continued REMUN
Page 43 and 44: Directors’ Report continued Share
Page 45 and 46: Directors’ Report continued Share
Page 47 and 48: Exercise Price Expiry Date Net othe
Page 49 and 50: Exercise Price Expiry Date Net othe
Page 51 and 52: Fair value per performance right at
Page 53: Directors’ Report continued REMUN
Page 57 and 58: Corporate Governance Statement cont
Page 67 and 68: Consolidated statement of fi nancia
Page 69 and 70: Consolidated statement of changes i
Page 71 and 72: Notes to the consolidated fi nancia
Page 73 and 74: Application date of standard Impact
Page 105 and 106:
Notes to the consolidated fi nancia
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Independent Auditor’s Report 111
Page 115 and 116:
Additional Shareholder Information
Page 117 and 118:
Additional Shareholder Information
Page 119:
corporate directory Phosphagenics L
show all

2013 Apr 15 Annual Report 2012 - Phosphagenics

Create successful ePaper yourself

Delete template?

Save as template?